Chemicals industry deal activity declined from both a value and volume perspective during the second quarter of 2019 to the lowest levels of any of the last 12 quarters largely attributable to the ongoing macroeconomic uncertainties including tariffs and rising geopolitical tensions. The largest announced transaction during the quarter was a $3.7 billion acquisition in the Specialty Chemicals category. Investments in and valuations in the Specialty Chemicals category continue to be the most sought after with dwindling supply.
“When thinking about Chemicals M&A, given the current macro-economic environment and trade wars taking shape, it has never been more essential to assess and reassess supply chains, understanding how new or proposed regulations and geopolitical tensions have or could impact the business or future transactions.”
Chemicals Leader, PwC US
Chemicals Deals Leader, PwC US
Chemical Deals Strategy Leader, PwC US
Deals Managing Director
China Inbound Deals Leader, PwC US